0000899243-21-024324.txt : 20210616
0000899243-21-024324.hdr.sgml : 20210616
20210616210019
ACCESSION NUMBER: 0000899243-21-024324
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210616
FILED AS OF DATE: 20210616
DATE AS OF CHANGE: 20210616
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CRANDELL KEITH
CENTRAL INDEX KEY: 0001219039
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40502
FILM NUMBER: 211023120
MAIL ADDRESS:
STREET 1: 8755 W. HIGGINS ROAD
STREET 2: SUITE 1025
CITY: CHICAGO
STATE: IL
ZIP: 60631
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BYBEE CLINTON
CENTRAL INDEX KEY: 0001219043
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40502
FILM NUMBER: 211023119
MAIL ADDRESS:
STREET 1: 8755 W. HIGGINS ROAD
STREET 2: SUITE 1025
CITY: CHICAGO
STATE: IL
ZIP: 60631
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ARCH Venture Fund IX, L.P.
CENTRAL INDEX KEY: 0001666306
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40502
FILM NUMBER: 211023124
BUSINESS ADDRESS:
STREET 1: 8755 W. HIGGINS ROAD, SUITE 1025
CITY: CHICAGO
STATE: IL
ZIP: 60631
BUSINESS PHONE: 773-380-6600
MAIL ADDRESS:
STREET 1: 8755 W. HIGGINS ROAD, SUITE 1025
CITY: CHICAGO
STATE: IL
ZIP: 60631
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ARCH Venture Fund IX Overage, L.P.
CENTRAL INDEX KEY: 0001666307
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40502
FILM NUMBER: 211023123
BUSINESS ADDRESS:
STREET 1: 8725 W. HIGGINS ROAD, SUITE 290
CITY: CHICAGO
STATE: IL
ZIP: 60631
BUSINESS PHONE: 773-380-6600
MAIL ADDRESS:
STREET 1: 8725 W. HIGGINS ROAD, SUITE 290
CITY: CHICAGO
STATE: IL
ZIP: 60631
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ARCH Venture Partners IX Overage, L.P.
CENTRAL INDEX KEY: 0001723172
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40502
FILM NUMBER: 211023122
BUSINESS ADDRESS:
STREET 1: 8755 W. HIGGINS ROAD
STREET 2: SUITE 1025
CITY: CHICAGO
STATE: IL
ZIP: 60631
BUSINESS PHONE: 773-380-6600
MAIL ADDRESS:
STREET 1: 8755 W. HIGGINS ROAD
STREET 2: SUITE 1025
CITY: CHICAGO
STATE: IL
ZIP: 60631
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ARCH Venture Partners IX, L.P.
CENTRAL INDEX KEY: 0001723173
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40502
FILM NUMBER: 211023121
BUSINESS ADDRESS:
STREET 1: 8755 W. HIGGINS ROAD
STREET 2: SUITE 1025
CITY: CHICAGO
STATE: IL
ZIP: 60631
BUSINESS PHONE: 773-380-6600
MAIL ADDRESS:
STREET 1: 8755 W. HIGGINS ROAD
STREET 2: SUITE 1025
CITY: CHICAGO
STATE: IL
ZIP: 60631
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ARCH Venture Partners IX, LLC
CENTRAL INDEX KEY: 0001723174
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40502
FILM NUMBER: 211023125
BUSINESS ADDRESS:
STREET 1: 8755 W. HIGGINS ROAD
STREET 2: SUITE 1025
CITY: CHICAGO
STATE: IL
ZIP: 60631
BUSINESS PHONE: 773-380-6600
MAIL ADDRESS:
STREET 1: 8755 W. HIGGINS ROAD
STREET 2: SUITE 1025
CITY: CHICAGO
STATE: IL
ZIP: 60631
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Lyell Immunopharma, Inc.
CENTRAL INDEX KEY: 0001806952
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 833006753
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 EAST JAMIE COURT
STREET 2: SUITE 301
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650 695-0677
MAIL ADDRESS:
STREET 1: 400 EAST JAMIE COURT
STREET 2: SUITE 301
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2021-06-16
0
0001806952
Lyell Immunopharma, Inc.
LYEL
0001723174
ARCH Venture Partners IX, LLC
8755 W. HIGGINS ROAD , SUITE 1025
CHICAGO
IL
60631
0
0
1
0
0001666306
ARCH Venture Fund IX, L.P.
8755 W. HIGGINS ROAD
SUITE 1025
CHICAGO
IL
60631
0
0
1
0
0001666307
ARCH Venture Fund IX Overage, L.P.
8755 W. HIGGINS ROAD
SUITE 1025
CHICAGO
IL
60631
0
0
1
0
0001723172
ARCH Venture Partners IX Overage, L.P.
8755 W. HIGGINS ROAD
SUITE 1025
CHICAGO
IL
60631
0
0
1
0
0001723173
ARCH Venture Partners IX, L.P.
8755 W. HIGGINS ROAD
SUITE 1025
CHICAGO
IL
60631
0
0
1
0
0001219039
CRANDELL KEITH
8755 W. HIGGINS ROAD
SUITE 1025
IL
60631
0
0
1
0
0001219043
BYBEE CLINTON
8755 W. HIGGINS ROAD
SUITE 1025
CHICAGO
IL
60631
0
0
1
0
Series A Convertible Preferred Stock
1.8288
Common Stock
17771216
I
ARCH Venture Fund IX, L.P.
Series A Convertible Preferred Stock
1.8288
Common Stock
17771216
I
ARCH Venture Fund IX Overage, L.P.
Series C Convertible Preferred Stock
11.4905
Common Stock
435142
I
ARCH Venture Fund IX, L.P.
Series C Convertible Preferred Stock
11.4905
Common Stock
435142
I
ARCH Venture Fund IX Overage, L.P.
The Series A Convertible Preferred Stock is convertible at any time, at the election of holder, has no expiration date, and will automatically convert to shares of the Issuer's Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-1 basis.
ARCH Venture Partners IX, L.P. (AVP IX LP) is the sole general partner of ARCH Venture Fund IX, L.P. (ARCH IX). ARCH Venture Partners IX Overage, L.P. (AVP IX Overage LP) is the sole general partner of ARCH Venture Fund IX Overage, L.P. (ARCH IX Overage). ARCH Venture Partners IX, LLC (AVP IX LLC) is the sole general partner of each of AVP IX LP and AVP IX Overage LP. Keith Crandell and Clinton Bybee are managing directors of AVP IX LLC (the AVP IX MDs). AVP IX LP and AVP IX Overage LP may be deemed to beneficially own the shares held by ARCH IX and ARCH IX Overage, respectively, AVP IX LLC may be deemed to beneficially own the shares held by ARCH IX and ARCH IX Overage, and each of the AVP IX MDs may be deemed to share the power to direct the disposition and vote of the shares held by ARCH IX and ARCH IX Overage. AVP IX LP, AVP IX Overage LP, AVP IX LLC, and the AVP IX MDs each disclaim beneficial ownership except to the extent of any pecuniary interest therein.
The Series C Convertible Preferred Stock is convertible at any time, at the election of holder, has no expiration date, and will automatically convert to shares of the Issuer's Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-1 basis.
/s/ ARCH Venture Fund IX, L.P., By: ARCH Venture Partners IX, L.P., its General Partner, By: ARCH Venture Partners IX, LLC, its General Partner, By: Mark McDonnell, attorney in-fact
2021-06-16
/s/ ARCH Venture Fund IX Overage, L.P., By: ARCH Venture Partners IX Overage, L.P., its General Partner, By: ARCH Venture Partners IX, LLC, its General Partner, By: Mark McDonnell, attorney in-fact
2021-06-16
/s/ ARCH Venture Partners IX, L.P., its General Partner, By: ARCH Venture Partners IX, LLC, its General Partner, By: Mark McDonnell, attorney in-fact
2021-06-16
/s/ ARCH Venture Partners IX Overage, L.P., its General Partner, By: ARCH Venture Partners IX, LLC, its General Partner, By: Mark McDonnell, attorney in-fact
2021-06-16
/s/ ARCH Venture Partners IX, LLC, its General Partner, By: Mark McDonnell, attorney in-fact
2021-06-16
/s/ Keith Crandell, By: Mark McDonnell, attorney in-fact
2021-06-16
/s/ Clinton Bybee, By: Mark McDonnell, attorney in-fact
2021-06-16